GIROCOVATEIN
UNII BAA4CV6ACY

Substance Identification & Data

This profile provides standardized clinical and technical data for Girocovatein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BAA4CV6ACY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3038651-03-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BAA4CV6ACY
CAS Registry Number
3038651-03-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GIROCOVATEIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C216033
National Cancer Institute reference terminology for clinical and research data.
INN ID
13661
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Girocovatein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GIROCOVATEIN

Common Names & Synonyms

316-533-SPIKE GLYCOPROTEIN (533-GLYCINE) (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VARIANT JN.1 PRECURSOR) FUSION PROTEIN WITH 316-533-SPIKE GLYCOPROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VARIANT JN.1 PRECURSOR)
GIROCOVATEIN [INN]
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), OMICRON LINEAGE JN.1 (GISAID: EPI_ISL_18872762) SPIKE (S) GLYCOPROTEIN RECEPTOR BINDING DOMAIN (RBD) FRAGMENT (303-520, 1-218 IN THE CURRENT SEQUENCE), VARIANT (K520>G218) FUSED TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), OMICRON LINEAGE JN.1 SPIKE (S) GLYCOPROTEIN RECEPTOR BINDING DOMAIN (RBD) FRAGMENT (303-520, 219-436 IN THE CURRENT SEQUENCE, K436>DEL), SINGLE CHAIN HOMODIMER, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus